Los agujeros negros se han convertido en las estrellas mediáticas. Conocemos su ferocidad, su gravedad insaciable y ese “horizonte de sucesos” del que ni siquiera la luz puede escapar. Sin embargo, las ecuaciones de la Relatividad General de Albert Einstein esconden una soluci&oacut …
¿Existen realmente los agujeros blancos, los gemelos invertidos de los agujeros negros? Read More »
En un panorama editorial saturado de libros apresurados sobre inteligencia artificial, inversiones y predicciones económicas, Futuro a la vista, cómo la IA y otras megatendencias darán forma a sus inversiones destaca como una obra extraordinariamente seria, lúcida y equil …
It’s not unusual for it to take unemployed biopharma professionals awhile to land new jobs. Three experts discuss when employment gaps are an issue and how to explain them to prospective employers.
How long is too long? Weighing and accounting for employment gaps Read More »
Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.
Edwards gets FDA approval for surgical tricuspid valve Read More »
Rising costs are eroding Americans’ trust in their commercial plans despite an industry-wide push to increase consumer satisfaction, the analytics firm found.
Consumers are less satisfied with their health plans: JD Power Read More »
FDA inspectors found that Medline, which raised billions of dollars last year, failed to prevent repeat bacterial contamination of finished drug products.
FDA hits Medline with warning letter over long-running contamination problem Read More »
Ardent elevated its former COO, Dave Caspers, to the top job as the Tennessee-based system grapples with its declining stock price.
In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.
MiniMed expands Abbott partnership to add dual glucose-ketone sensor Read More »
Strength in cardiac ablation solutions, where the company picked up market share, helped Medtronic post its best annual revenue growth rate in a decade.
Medtronic boosts revenue by nearly double digits in Q4 Read More »
Revolution Medicines stole the show at the 2026 American Society of Clinical Oncology meeting as full data from its pancreatic cancer drug lived up to expectations, while Summit and Akeso proved the PD-(L)1/VEGF mechanism and Eli Lilly showed that its in vivo CAR T bet is paying off.
ASCO’s biggest winners showcased a new era of cancer innovation Read More »
